Cold Chain Professionals Trend to Increase Investment over the Next 10 Years

Nov. 16, 2011 - PRLog -- The pharmaceutical industry's 'cold chain', the controlled route along which temperature-sensitive products are distributed, plays a critical role in ensuring the shelf life and integrity of medicines and biologics. Most supply chains of this kind are optimised somewhere between 2 and 8 degrees C, but the actual tolerances depend on the specific goods being transported.

An efficient, unbroken cold chain really comes into its own when shipments of vaccines need to travel long distances in hot climates which may be served by poorly developed transport infrastructure. The cold chain distribution process is an extension of the good manufacturing practice (GMP) environment that all pharma and biological products must adhere to.

Pharma IQ recently surveyed key members of the pharma, biotech and logistics communities, ahead of the 11th annual Cool Chain Logistics Europe event being held in Switzerland in January.


The 11th Annual Cool Chain Logistics Europe event will be hosted from 30th January to 1st February 2012 in Basel, Switzerland. For more details, visit: www.coolchaineurope.com email: enquire@iqpc.co.uk or call freephone: 0800 652 2363.

To download this Report in full please click here: http://www.coolchaineurope.com/Event.aspx?id=550992&utm_c...